{"url_path":"/sec/ccrn/8-k/2026-07-06/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1141103/0000950103-26-010220-index.html","accession_number":"0000950103-26-010220","cik":"0001141103","ticker":"CCRN","issuer_name":"CROSS COUNTRY HEALTHCARE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1141103/0000950103-26-010220-index.html","primary_entity_key":"0001141103","primary_entity_name":"CROSS COUNTRY HEALTHCARE INC"},"word_count":286,"has_tables":true,"body_markdown":"false\n0001141103\n\n0001141103\n\n2026-07-06\n2026-07-06\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n**UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION****Washington, D.C. 20549**\n\n____________________________\n\n \n\n**Form 8-K**\n\n____________________________\n\n \n\n**Current Report\nPursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934\nDate of Report (Date of earliest event reported): July 6, 2026**\n\n____________________________\n\n \n\n**Cross Country\nHealthcare, Inc.****(Exact name of registrant as specified in its charter)**\n\n____________________________\n\n \n\n**Delaware**\n**0-33169**\n**13-4066229**\n\n**(State or other jurisdiction\nof incorporation)**\n**(Commission\nFile Number)**\n**(IRS Employer\nIdentification No.)**\n\n \n\n**5201 Congress Avenue, Suite 160, Boca Raton,\nFL 33487\n(Address of principal executive offices) (Zip Code)**\n\n \n\n**(561) 998-2232\n(Registrant's telephone number, including area code)**\n\n \n\n**Not Applicable\n(Former name or former address, if changed since last report.)**\n\n____________________________\n\n \n\n☒Written communications pursuant\nto Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n☐Soliciting material pursuant to\nRule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n☐Pre-commencement communications\npursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n☐Pre-commencement communications\npursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant\nto Section 12(b) of the Act:\n\n \n\n**Title of each class**\n**Trading Symbol**\n**Name of each exchange on which registered**\n\nCommon Stock, par value $0.0001 per share\nCCRN\nNASDAQ Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the\nSecurities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐"}